RNS Number : 3254I
  Medilink-Global UK Limited
  18 November 2008
   

    Tuesday 18 November 2008
    MediLink-Global UK Limited
    ("Medilink", "the Group" or "the Company")

    Admission to Trading on AIM

    Placing to raise �2.1m before expenses

    MediLink-Global UK Limited (AIM: MEDI), the electronic healthcard network service provider, announces the successful admission to
trading on AIM today.  The Company raised �2.1 million before expenses at a Placing Price of 18 pence per share and at admission the company
is valued at �18.6 million.  The net placing proceeds will be used to provide working capital to fund the expansion of the healthcare
network, initially across China but also into other new territories. 

    The Group has appointed Dowgate Capital Advisers Limited as its Nominated Adviser (NOMAD) and SVS Securities plc as its Financial
Adviser and Broker.

    Key Information about Medilink:

    *     The Medilink System was created in late 2002 in Kuala Lumpur. It provides electronic healthcard network services to insurance and
other companies and third party administrators to facilitate the administration of medical claims and healthcare data management.

    *     The Medilink System provides members with an electronic swipe card which, on presentation, allows the Healthcare Service Providers
to electronically assess whether the member is eligible for insurance cover relevant to their condition.

    *     The Medilink System is now well established in the Malaysian healthcare industry. The Group has successfully secured two major
accounts with its principal clients. The Company has now installed the Medilink System through a network of over 100 hospitals and 2,000
clinics. To date the Company has issued over 1.8 million cards to Malaysian members. 

    *     The Directors believe that the Company is the only operator in Malaysia to provide a real-time electronic insurance verification
system. As such, it facilitates easier medical claims for members and can be used as a selling point for insurance companies to recruit
corporate clients.

    *     Following an agreement with ING, in 2006 an initial 1,800 EDC terminals were deployed throughout Malaysia. In 2007 the Group
signed its first software license with Great Eastern Life Assurance (Malaysia) Berhad.

    *     In 2006 the Group secured its first contract in China with Generali China Life Insurance Co. Ltd. To date, MidLink has established
a network of approximately 100 Healthcare Providers across ten key Chinese cities and over 33,000 cards have been issued to Chinese members.
The Directors believe that there is a considerable opportunity in China and an implied market potential of some RMB 489 billion.

    Placing Statistics

 Placing Price                                                        18 pence
 Number of Ordinary Shares in issue prior to the Placing and        90,002,000
 Admission
 Number of Placing Shares                                           11,666,666
 Number of shares to be issued in connection with services           1,661,964
 provided pursuant to the Placing and Admission
 Number of Ordinary Shares in issue following the Placing          103,330,630
 Percentage of the Enlarged Share Capital subject to the                11.29%
 Placing
 Gross proceeds receivable by the Company pursuant to the         �2.1 million
 Placing
 Market Capitalisation at the Placing Price on Admission         �18.6 million

    Enquiries:

 MediLink-Global UK Limited                     Tel: +603 22 963 028
 Shia Kok Fat, Chief Executive Officer          http://www.medilink-global.com

 Dowgate Capital Advisers Limited (Nominated    Tel: 020 7492 4777
 Adviser)
 Liam Murray

 SVS Securities Plc (Financial Adviser and      Tel: 020 7638 5600
 Broker)
 Ian Callaway

 Parkgreen Communications Limited               Tel: 020 7933 8787
                                                Mob: 07980 541 893
                                                paul.mcmanus@parkgreen


    Further information on the Company, the Placing and Admission can be found below. This information should be read in conjunction with
the full Admission Document.

    Current Trading and Prospects

    The Board considers that the prospects for the Group are promising. Although competition in the sector is expected to intensify, the
Directors believe that the Group has a competitive advantage through the development of the Medilink System and they remain committed to
devoting significant resources to ensure the Group's success in the market.

    Current trading is proceeding satisfactorily. Group revenues for the period ended 30 June 2008 reflect an increase of approximately 33
per cent. over the same period last year, although the Directors anticipate that the greater part of the Group's revenues will arise in the
second half of the year. 

    During the first six months of 2008 the Group has signed a number of new contracts including:

    *     Via its strategic alliance agreement with MidLink, an agreement to facilitate third party administrator services for Ping An
Retirement Insurance Co. Ltd.
    * A memorandum of understanding with Sunshine Insurance Group Corporation Limited for the provision of the Medilink System's electronic
healthcard network system in China.            * A contract with CIMB-Aviva Takaful Berhad to support the air travel insurance policies of
Firefly, a subsidiary of  Malaysia  Airlines.
    The Company is in negotiations with a number of other potential clients and anticipates it will sign further contracts during the second
half of the current financial year. A number of these prospects come from existing relationships in Malaysia that are being extended to new
regions.

    Board of Directors

    Norman Lott, Non-Executive Chairman (UK)

    Mr Lott is an associate member of the Institute of Chartered Accountants in England and Wales and is the part-time finance director of
ReGen Therapeutics Plc and various other public and private companies. Prior to taking up his present positions Mr Lott was the finance
director and deputy managing director of Tiger Books International Plc, financial controller of Mary Glasgow Publications and Parks
Bookshops Ltd (each part of Wolters Kluwer (UK) Plc), UK finance director of FTC Holdings Plc, finance director of Flowsave International
and Graham & Trotman Ltd, financial controller of Stromberg (UK) Ltd and an assistant manager with Peat Marwick (Hong Kong).

    Shia Kok Fat, Chief Executive Officer

    An accountant by training, Mr Shia, a Malaysian, served as an internal audit manager in a publicly listed telecommunications company,
Telekom Malaysia Berhad, for eight years during which he was involved in formulating financial policies and procedures, reviewing
operational and financial systems and transactions as well as streamlining business processes. Subsequently he spent four years in a
software development and systems consulting environment where he worked on many computerisation projects for medical clinics and hospitals.
Prior to founding the Group he spent three years in healthcare management and consulting for a managed care organization with 135,000
members. A founder-member and substantial shareholder of the Group, Mr Shia is principally responsible for the Group's strategy and
direction.

    Yap Tai Tee, Executive Director

    Mr Yap, a Malaysian, is a promoter, substantial shareholder and the group managing director/chief executive officer of Asdion, a company
listed on the MESDAQ Market of Malaysia. He was appointed to the board of directors of Asdion on 30 September 2004. In 1987 he obtained a
diploma in electrical engineering from the Singapore Polytechnic, Singapore. In 1989, he graduated from Lancaster University, United
Kingdom, with a BSc (Hons) in information engineering with first class honours. He is also currently the general manager of Techtron
Integrated System (S) Pte Ltd ("TIS"), a position he has held since 1995. In this position he is responsible, inter alia, for overseeing and
managing the entire operations of TIS. Prior to joining TIS in 1993 as the marketing manager he was a research associate with Koeneman
Capital Management Pte Ltd. 

    Chen Shien Yee, Finance Director

    Mr Chen, a Malaysian, is a Fellow of the Association of Chartered Certified Accountants and an Associate Member of the Malaysian
Institution of Accountants. He has over 12 years experience in auditing, tax consultancy and secretarial and financial accounting advisory
services. Prior to joining the Group in July 2008 he held positions as an equity partner in FKL & Associates (Chartered Accountants), chief
financial officer of Rhythm Consolidated Bhd (a company engaged in publishing, printing, franchising and information communication
technology), general manager of finance and accounts of Dataprep Holdings Bhd (an information technology company), head of finance and
accounts of L&M Corporation Group of Companies, (a company engaged in construction and investment holding) and group accountant of Taman
Industri Selangor Sdn Bhd (a property manager and developer).

    Ng Lai Siang, Non-Executive Director

    Ms Ng, a Malaysian, currently holds an audit and tax license issued by the Ministry of Finance in Malaysia. She held the position of
audit/tax manager & company secretary for seven years in Hun & Co prior to her tenure in 2001 and 2002 as a senior audit manager in SY
Kwong, Foong & Co., where she was involved in strategic planning and in-house training. In 2002 she founded LS Ng & Associates and MLTT
Management Services, which provides a variety of business services. She joined the Board on 25 July 2008.


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
MSCEAKFXFDXPFFE

Medilink (LSE:MEDI)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Medilink Charts.
Medilink (LSE:MEDI)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Medilink Charts.